⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 1, 2024Open Access

Supplementary Figure S7 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

Tista Roy Chaudhuri Qingxiang Lin Ewa K. Stachowiak Spencer R. Rosario Joseph A. Spernyak Wen Wee Michal K. Stachowiak Michelle K. Greene Gerard P. Quinn Simon S. McDade Martin Clynes Christopher J. Scott Robert M. Straubinger

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary Figure S7. Kinase enrichment analysis of differentially-expressed genes after SHHi treatment

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chaudhuri et al. (2024) studied this question.

synapsesocial.com/papers/68e712deb6db64358768c06e https://doi.org/10.1158/1078-0432.25515931.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S7 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors2024
2Supplementary Figure S6 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors2024
3Supplementary Figure S6 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors2024
4Supplementary Figure S5 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors2024
5Supplementary Figure S5 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors2024

More related papers

Supplementary Figure S9 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors2024
Supplementary Figure S9 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors2024
Supplementary Figure S4 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors2024